Opaleye Management Inc.
HROWOpaleye Management Inc. serves as 10 percent owner at Harrow Health, Inc. (HROW). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Opaleye Management Inc.'s Insider Trading at Alpha Cognition Inc. Common Stock (ACOG)
Buys
24 · $7.82M
Sells
0 · $0.00
Total Shares Bought
1,127,473
Total Shares Sold
0
Opaleye Management Inc.'s Insider Trading at Eton Pharmaceuticals, Inc. (ETON)
Buys
0 · $0.00
Sells
2 · $5.83M
Total Shares Bought
0
Total Shares Sold
155,000
Opaleye Management Inc.'s Insider Trading at SANUWAVE Health, Inc. (SNWV)
Buys
0 · $0.00
Sells
3 · $2.19M
Total Shares Bought
0
Total Shares Sold
122,698
Opaleye Management Inc.'s Insider Trading at Harrow Health, Inc. (HROW)
Buys
0 · $0.00
Sells
3 · $2.05M
Total Shares Bought
0
Total Shares Sold
45,000
Opaleye Management Inc.'s Insider Trading at Protara Therapeutics, Inc. (TARA)
Buys
0 · $0.00
Sells
9 · $952.9K
Total Shares Bought
0
Total Shares Sold
450,275
Opaleye Management Inc.'s Insider Trading at Grace Therapeutics, Inc. (GRCE)
Buys
9 · $560.5K
Sells
0 · $0.00
Total Shares Bought
288,019
Total Shares Sold
0
Showing 1–50 of 94
Related Insiders
David Krempa
officer: Chief Business Officer
Prashant Kohli
director, officer: Chief Executive Officer
MAIER PAUL V
director
BRYNJELSEN SEAN
President & CEO
Jennifer McKie Adams
director
RIEDEL NORBERT G
Director
James R. Gruber
Chief Financial Officer
Ipek Erdogan-Trinkaus
Chief Commercial Officer